Jabberwocky
Frumious Bandersnatch
As a result of our ongoing work with research groups and academic institutions around the globe, Bluelight was recently thanked for our assistance in enrolling a recent survey on Mephedrone published in the journal, Neuropsychopharmacology.
Here is the abstract to the actual paper:
----------------------------------------------------
A web-based survey on mephedrone
R.L. Carhart-HarrisCorresponding Author Contact Information, a, E-mail The Corresponding Author, L.A. Kinga and D.J. Nutta
a Imperial College London, Neuropsychopharmacology Unit, United Kingdom
Received 7 November 2010;
revised 3 February 2011;
accepted 12 February 2011.
Available online 21 March 2011.
Background
This study sought to collect information on the former legal-high ‘mephedrone’ using a web-based survey targeted at mephedrone users.
Methods
The survey was advertised on websites frequented by drug users. Individuals were invited to complete the survey if they had taken mephedrone on at least one occasion in the past.
Results
One thousand and six completed forms were received from declared users, making this the largest survey on mephedrone to date.
Conclusion
Results showed that mephedrone users consider its effects to compare best with those of MDMA, and while MDMA was considered marginally safer and its effects more pleasurable, mephedrone's appeal lay in its availability, low price and reliable purity.
Keywords: Mephedrone; MDMA; Ecstasy; Cathinone; Stimulant; Legal high; Drugs; Harms
Article Outline
1.
Introduction
2.
Methods
3.
Results
3.1. Basic and demographic data
3.2. Mephedrone use parameters
3.3. Impact of the ban
3.4. Mephedrone and MDMA
3.5. Negative effects
4.
Discussion
Role of funding source
Contributors
Conflict of interest
Acknowledgements
Appendix A.
Supplementary data
References
---------------------------------------------------
Thanks to all who participated in the survey hosted in our Drug Studies forum - Mephedrone survey
SG
Acknowledgements:
We would like to thank Sophie Macken and Will McMahon for their input and support, Bristol Online Surveys for providing an easy-to-use facility to build the survey, and www.drugs-forum.com and www.bluelight.ru for their crucial help in advertising the survey.
Here is the abstract to the actual paper:
----------------------------------------------------
A web-based survey on mephedrone
R.L. Carhart-HarrisCorresponding Author Contact Information, a, E-mail The Corresponding Author, L.A. Kinga and D.J. Nutta
a Imperial College London, Neuropsychopharmacology Unit, United Kingdom
Received 7 November 2010;
revised 3 February 2011;
accepted 12 February 2011.
Available online 21 March 2011.
Background
This study sought to collect information on the former legal-high ‘mephedrone’ using a web-based survey targeted at mephedrone users.
Methods
The survey was advertised on websites frequented by drug users. Individuals were invited to complete the survey if they had taken mephedrone on at least one occasion in the past.
Results
One thousand and six completed forms were received from declared users, making this the largest survey on mephedrone to date.
Conclusion
Results showed that mephedrone users consider its effects to compare best with those of MDMA, and while MDMA was considered marginally safer and its effects more pleasurable, mephedrone's appeal lay in its availability, low price and reliable purity.
Keywords: Mephedrone; MDMA; Ecstasy; Cathinone; Stimulant; Legal high; Drugs; Harms
Article Outline
1.
Introduction
2.
Methods
3.
Results
3.1. Basic and demographic data
3.2. Mephedrone use parameters
3.3. Impact of the ban
3.4. Mephedrone and MDMA
3.5. Negative effects
4.
Discussion
Role of funding source
Contributors
Conflict of interest
Acknowledgements
Appendix A.
Supplementary data
References
---------------------------------------------------
Thanks to all who participated in the survey hosted in our Drug Studies forum - Mephedrone survey
SG
Last edited by a moderator: